Harmonizing standards and resources for the medical genome
E.A.A. is a founder of Personalis, Deepcell, Svexa, Saturnus Bio and Swift Bio; an advisor to Pacific Biosciences; and a non-executive director of AstraZeneca and Dexcom. N.J.L. is an advisor to Everygene Collaborative, and has received support in kind from Illumina, Pacific Biosciences and Ultima. B.R.R. is an advisor to Autonomous Therapeutics and GC Therapeutics. B.P. is a consultant to Calico Life Sciences and Bimodal, and an advisor to the California Institute for Regenerative Medicine. F.J.S. has received research support from Illumina, PacBio and Oxford Nanopore. K.K. is a scientific advisor to CareDx and Eledon Pharmaceuticals. A.M. is a cofounder of Site Therapeutics, Arsenal Biosciences, Spotlight Therapeutics and Survey Genomics; serves on the boards of directors at Site Therapeutics, Spotlight Therapeutics and Survey Genomics; is a member of the scientific advisory boards of Site Therapeutics, Arsenal Biosciences, Spotlight Therapeutics, Survey Genomics, NewLimit, Amgen and Tenaya; owns stock in Arsenal Biosciences, Site Therapeutics, Spotlight Therapeutics, NewLimit, Survey Genomics, Tenaya and Lightcast; has received fees from Site Therapeutics, Arsenal Biosciences, Spotlight Therapeutics, NewLimit, 23andMe, PACT Pharma, Juno Therapeutics, Tenaya, Lightcast, Trizell, Vertex, Merck, Amgen, Genentech, GLG, ClearView Healthcare, AlphaSights, Rupert Case Management, Bernstein and ALDA; and is an investor in and informal...